Choice - Best Stock Broker in India
  • About
  • App
  • Services
    Services
  • Research
  • Partners
  • Contact
  • Log In
  • Open Demat Account
Best Large Cap Mutual Funds

Key Benefits of Investing in Pharma and Healthcare Mutual Funds

  • Defensive Sector : Healthcare spending remains stable regardless of economic conditions, providing portfolio resilience
Show more

Invest in Best Pharma Sector Mutual Funds in India for 2025

Explore the list of top-performing pharma sector mutual funds schemes curated by our experts

SBI Healthcare Opportunities Fund Growth

  • Returns
    20.5%
  • Lock-In
    No Lock in
  • Min Investment
    ₹ 5000
  • Choice Rating

ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth

  • Returns
    21.2%
  • Lock-In
    No Lock in
  • Min Investment
    ₹ 5000
  • Choice Rating

DSP Healthcare Fund Growth

  • Returns
    19.2%
  • Lock-In
    No Lock in
  • Min Investment
    ₹ 100
  • Choice Rating

UTI Healthcare Fund Growth

  • Returns
    18.8%
  • Lock-In
    No Lock in
  • Min Investment
    ₹ 5000
  • Choice Rating

Nippon India Pharma Fund Growth

  • Returns
    18.6%
  • Lock-In
    No Lock in
  • Min Investment
    ₹ 5000
  • Choice Rating
12

You would have got

Total Investment
₹ 1200
Expected Returns
₹ 58
Total Value
₹ 1258

Past performance doesn’t assure future results; actual outcome may vary due to market dynamics.

Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5
per annum

Understanding Pharma and Healthcare Funds

How Do Pharma and Healthcare Mutual Funds Work?

Pharma and Healthcare Mutual Funds pool investments from multiple investors to create a diversified portfolio within the healthcare sector. Professional fund managers analyse industry trends, regulatory environments, and company fundamentals to select stocks with strong growth potential. These funds typically maintain 80% of their assets in healthcare and pharmaceutical companies, balancing established manufacturers with emerging healthcare technology firms.

The sector's essential nature and continuous innovation provide stability and growth opportunities. This combination of defensive characteristics and innovation-driven growth makes healthcare funds in India particularly valuable for investors seeking sector-specific exposure with long-term potential.

Pharma and Healthcare Mutual Funds FAQs

Explore More Mutual Funds Options

Diversify your portfolio with our collection of high-performing mutual funds across various categories.  Compare, choose, and invest in India's top-rated funds to meet your financial goals.

Best ELSS Mutual Funds
Tax Saving (ELSS) Funds
Top Mid Cap Mutual Funds
Mid Cap Funds
Best Large Cap Mutual Funds
Large Cap Funds
Best Small Cap Mutual Funds
Small Cap Funds
Best Multi Cap Mutual Funds
Multicap Funds

Open Account Now

Official Choice India Logo
  • Services

  • Stocks
  • Mutual Funds
  • Wealth Planning
  • Insurance
  • Loans
  • Capital Advisory
  • Management Consultancy
  • Government Advisory
  • Institution
  • Company

  • Our Team
  • Investors
  • Calculator
  • Careers
  • Contact Us
  • Refer & Earn
  • FAQ’s
  • Resources

  • Fundamental
  • Technical
  • Blog
  • Pricing
  • Downloads
  • News & Media
  • Offer Document
  • Track Record
  • Investor Charter
  • Investor Grievances
  • Online KYC Updation
  • Quick Links

  • Open Demat Account
  • Corporate Demat Account
  • NRI Demat Account
  • Minor Demat Account
  • Market Prediction
  • Lowest Brokerage
  • Investor Charter
  • Investor Awareness
  • Watchout Investors
  • Investor's Advisory
  • Disclaimer
  • CEBPL Policies & Disclosures
  • CFPL Policies & Disclosures
  • Sachet Portal
  • Direct Pay-in

Choice International Limited , Sunil Patodia Tower,
J B Nagar, Andheri(East),
Mumbai 400099.

Monday - Friday : 08:30 am - 7:00 pm
Saturday : 10:00 am - 4:00 pm

+91-88-2424-2424

care@choiceindia.com

Certification Badge - Choice India Is A Great Place To Work
Google Play
App Store Choice India App On Ios DevicesApp Store
  • Made with in India
  • Privacy Policy
  • Terms & Conditions

Choiceinternational. CIN - L67190MH1993PLC071117
Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ).
Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015 , DP ID CDSL - 12066900 , NSDL ID - IN301895. Research Analyst - INH000000222
Choice Wealth Private Limited: AMFI - Registered Mutual Fund Distributor. Association of Mutual Funds in India Registration Number - ARN - 78908.
Initial Registration: 15th March 2010 Valid Till: 14th March 2027.
Pension Fund Regulatory and Development Authority (PFRDA) - POPSE52022022 | Affiliated with POP HDFC Pension Management Company.
Choice Finserv Private Limited: NBFC Registration Number : N - 13.02216

Choice Insurance Broking Private Limited: IRDAI License No: 167, License Valid Till: 29-05-2025 | Category : Direct ( Life & General )
Registered Office: Choice International Limited, Sunil Patodia Tower, J B Nagar, Andheri East, Mumbai, Maharashtra 400099.
For any Grievances / Queries email at ig@choiceindia.com & care@choiceindia.com | Online Dispute Resolution Link: https://smartodr.in/login

Cautionary Message :

  1. Sharing of trading credentials – login id & passwords including OTP’s:- Keep Your Password/Pin and OTP’s private & confidential to avoid any misuse or unauthorised trades. Please ensure that you do not share it with any one.
  2. Trading in leveraged products like options without proper understanding, which could lead to losses
  3. Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks
  4. Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, calls, etc.
  5. Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers

Disclaimer:
1. *Investments in securities market are subject to market risks, read all the related documents carefully before investing.
2. In addition to client based business, we are also doing proprietary trading.
3. Brokerage will not exceed the SEBI prescribed limit.

Research Disclaimer and Disclosure inter-alia as required under Securities and Exchange Board of India (Research Analysts) Regulations, 2014

Choice Equity Broking Private Limited (“CEBPL”) is a registered Research Analyst Entity (Reg. No. INH000000222 ) (hereinafter be referred as “CEBPL”). (CIN. NO.: U65999MH2010PTC198714).

Reg. Address: Sunil Patodia Tower, J B Nagar, Andheri(East), Mumbai 400099. Tel. No. 022-6707 9999 .

Compliance Officer: Mr.Prashant Salian. Tel. 022-67079999 - Ext-2310
Email- Prashant.salian@choiceindia.com

Grievance officer: Deepika Singhvi Tel.022-67079999- Ext-834.
Email- ig@choiceindia.com

Research Disclaimer: Investment in the securities market is subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

© Choice International Limited. All Rights Reserved.